Scrip Id
NOVELIX
Novelix Pharmaceuticals Limited has submitted a regulatory disclosure to the BSE Limited, addressed to the Deputy Manager of the Department of Corporate Services. The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company informs that it has opened a new corporate office located at "Flat No-308B, 3rd floor, Block B, 'The Platina' Kondapur Road, Gachibowli, Hyderabad, Serilingampally, Ranga Reddy, Telangana, India, 500032". The new office became operational with effect from 16th November, 2026.
This decision was an outcome of a meeting of the Board of Directors of the Company held on 11th November, 2026. The company has requested BSE to take this information on record and disseminate it through their website.
The letter is signed by Gnana Plakash Ghitu, Whole-Time Director (DIN: 00517921) on behalf of Novelix Pharmaceuticals Limited. The company's registered office address remains H No: j-6-217/61o, Flat No:61o,6th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 500029.
No financial impact, capital expenditure details, or operational rationale for the move are quantified or disclosed in the filing.